BiBBInstruments AB (XSAT:BIBB)
0.6900
0.00 (0.00%)
At close: Aug 6, 2026
BiBBInstruments AB Company Description
BiBBInstruments AB, a medical technology company, develops and markets electrically powered endoscopic biopsy systems in the United States and Europe.
The company offers EndoDrill which enables tissue sampling, with the aim of improving diagnostics in several common cancers, including those affecting the pancreas, stomach, liver, lungs, and urinary bladder.
It also provides EndoDrill GI which used for endoscopic ultrasound; EndoDrill EBUS is used in the airways during endobronchial ultrasound (EBUS); and EndoDrill URO that is used with a standard cystoscope for sampling of muscle-invasive bladder cancer.
The company was incorporated in 2013 and is headquartered in Lund, Sweden.
BiBBInstruments AB
| Country | Sweden |
| Founded | 2013 |
| Industry | Surgical and Medical Instruments and Apparatus |
| Employees | 4 |
| CEO | Fredrik Lindblad |
Contact Details
Address: Medicon Village Lund, 223 81 Sweden | |
| Phone | 46 7 08 99 94 86 |
| Website | bibbinstruments.se |
Stock Details
| Ticker Symbol | BIBB |
| Exchange | Spotlight Stock Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Fredrik Lindblad | Chief Executive Officer |